Immunotherapy may be effective for subset of prostate cancer

(Beth Israel Deaconess Medical Center) Researchers report that about a quarter of localized prostate cancers may demonstrate immunologic traits that would allow a substantial number of patients with prostate cancer to benefit from immunotherapies.